New Drug Application News and Research

RSS
NIAID awards more than $12 million for the development of antiviral therapies

NIAID awards more than $12 million for the development of antiviral therapies

False positive monkeypox tests in low-risk patients with no exposures

False positive monkeypox tests in low-risk patients with no exposures

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Modifi Bio comes up with a new technology to combat cancer cells with DNA modification

Modifi Bio comes up with a new technology to combat cancer cells with DNA modification

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

City of Hope's late-breaking clinical trial data to be presented at AACR

City of Hope's late-breaking clinical trial data to be presented at AACR

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

FDA warns two companies for illegal marketing of unapproved CBD products

FDA warns two companies for illegal marketing of unapproved CBD products

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

FDA-approved drug has limited treatment efficacy for hypoactive sexual desire disorder

FDA-approved drug has limited treatment efficacy for hypoactive sexual desire disorder

Intranasal COVID-19 vaccine candidate preclinically tested at UAB expected to start clinical trial

Intranasal COVID-19 vaccine candidate preclinically tested at UAB expected to start clinical trial

Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

FDA approves first generic glucagon for injection to treat severe hypoglycemia

FDA approves first generic glucagon for injection to treat severe hypoglycemia

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine